The results demonstrated that the intravenous administration of Tf‐anchored TiO2 nanoparticles and clinically employed radionuclides efficiently suppressed the tumor growth (Figure 10d) accompanied with prolonged survival rate of tumor‐bearing mice (Figure 10e). This evidence concerns the gene TF and neoplasm.